[{"address1": "201 Haskins Way", "address2": "Suite 230", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "(650) 407-2376", "website": "https://www.cero.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. Christopher B. Ehrlich M.B.A.", "age": 54, "title": "CEO & Chair", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1080000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew Albert Kucharchuk M.B.A.", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 252000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kristen  Pierce Ph.D.", "age": 53, "title": "Chief Development Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 360000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lawrence  Corey M.D.", "age": 77, "title": "Co-founder & Head of Scientific Advisory Board", "yearBorn": 1947, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.068, "open": 0.07, "dayLow": 0.0632, "dayHigh": 0.0748, "regularMarketPreviousClose": 0.068, "regularMarketOpen": 0.07, "regularMarketDayLow": 0.0632, "regularMarketDayHigh": 0.0748, "payoutRatio": 0.0, "volume": 59882, "regularMarketVolume": 59882, "averageVolume": 2577568, "averageVolume10days": 683500, "averageDailyVolume10Day": 683500, "bid": 0.066, "ask": 0.069, "bidSize": 30245, "askSize": 10000, "marketCap": 128695, "fiftyTwoWeekLow": 0.05, "fiftyTwoWeekHigh": 510.0, "allTimeHigh": 25600.0, "allTimeLow": 0.05, "fiftyDayAverage": 2.81464, "twoHundredDayAverage": 11.7561, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 9000200, "forwardPE": -0.0276, "profitMargins": 0.0, "floatShares": 20657827, "sharesOutstanding": 1865147, "sharesShort": 192892, "sharesShortPriorMonth": 106183, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.1034, "heldPercentInsiders": 0.00153, "heldPercentInstitutions": 0.01044, "shortRatio": 0.83, "shortPercentOfFloat": 0.105, "impliedSharesOutstanding": 1865147, "bookValue": -8.849, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": 14205841, "trailingEps": -4.41, "lastSplitFactor": "1:20", "lastSplitDate": 1749772800, "enterpriseToEbitda": -0.524, "52WeekChange": -0.99979883, "SandP52WeekChange": 0.09209216, "quoteType": "EQUITY", "currentPrice": 0.069, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 2022072, "totalCashPerShare": 0.096, "ebitda": -17184494, "totalDebt": 931023, "quickRatio": 0.239, "currentRatio": 0.302, "returnOnAssets": -2.10219, "grossProfits": -500000, "freeCashflow": -10112126, "operatingCashflow": -13813913, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CERO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 1.4705801, "regularMarketPrice": 0.069, "marketState": "CLOSED", "shortName": "CERo Therapeutics Holdings, Inc", "longName": "CERo Therapeutics Holdings, Inc.", "exchange": "NCM", "messageBoardId": "finmb_1673740339", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1638282600000, "regularMarketChange": 0.0009999946, "corporateActions": [{"header": "Delisting", "message": "CERO was delisted effective Oct. 31, 2025", "meta": {"eventType": "DELISTING", "dateEpochMs": 1761886800000}}], "regularMarketTime": 1763758772, "regularMarketDayRange": "0.0632 - 0.0748", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2577568, "fiftyTwoWeekLowChange": 0.018999998, "fiftyTwoWeekLowChangePercent": 0.37999994, "fiftyTwoWeekRange": "0.05 - 510.0", "fiftyTwoWeekHighChange": -509.931, "fiftyTwoWeekHighChangePercent": -0.9998647, "fiftyTwoWeekChangePercent": -99.97988, "epsTrailingTwelveMonths": -4.41, "epsCurrentYear": -4.29, "priceEpsCurrentYear": -0.016083917, "fiftyDayAverageChange": -2.74564, "fiftyDayAverageChangePercent": -0.9754853, "twoHundredDayAverageChange": -11.687099, "twoHundredDayAverageChangePercent": -0.9941307, "priceToBook": -0.0077974913, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Phoenix Biotech Acquisition Corp.", "nameChangeDate": "2025-11-21", "averageAnalystRating": "3.0 - Hold", "cryptoTradeable": false, "displayName": "CERo Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]